Felicitas Vernen
Overview
Explore the profile of Felicitas Vernen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benfield A, Vernen F, Young R, Nadal-Bufi F, Lamb H, Hammerlindl H, et al.
Pharmacol Res
. 2024 Jul;
207:107298.
PMID: 39032840
Acquired drug resistance is the major cause for disease recurrence in cancer patients, and this is particularly true for patients with metastatic melanoma that carry a BRAF mutation. To address...
2.
Vernen F, Craik D, Lawrence N, Troeira Henriques S
ACS Chem Biol
. 2019 Nov;
14(12):2895-2908.
PMID: 31714739
Tachyplesin-I (TI) is a host defense peptide from the horseshoe crab that has outstanding potential as an anticancer therapeutic lead. Backbone cyclized TI (cTI) has similar anticancer properties to TI...
3.
Vernen F, Harvey P, Dias S, Veiga A, Huang Y, Craik D, et al.
Int J Mol Sci
. 2019 Aug;
20(17).
PMID: 31455019
Tachyplesin I, II and III are host defense peptides from horseshoe crab species with antimicrobial and anticancer activities. They have an amphipathic β-hairpin structure, are highly positively-charged and differ by...
4.
Adarme-Vega T, Lim D, Timmins M, Vernen F, Li Y, Schenk P
Microb Cell Fact
. 2012 Jul;
11:96.
PMID: 22830315
Omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) provide significant health benefits and this has led to an increased consumption as dietary supplements. Omega-3 fatty acids EPA and...